Use of Bone Scintigraphy, CT and MRI in Breast Cancer
- Conditions
- Breast Neoplasms
- Registration Number
- NCT00682253
- Lead Sponsor
- University of Aarhus
- Brief Summary
A new imaging modality combining CT and tomographic bone scintigraphy (SPECT/CT) has enabled the combination of functional and anatomical imaging. Its use in cancer patients has not yet been evaluated or validated against a relative gold stand or clinical follow up. The purposes of this study are: 1: to validate the use of conventional planar bone scintigraphy and SPECT combined with low-dose or diagnostic CT and compare this to 3 Tesla MRI and clinical follow up. 2: to compare the specificity of low-dose and diagnostic CT, respectively, combined with bone SPECT. 3: to construct an algorithm for optimal evaluation of disease dissemination in breast cancer patients
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
- Histological verified breast cancer
- Age 18-80 years
- Investigation for metastases using imaging modality/modalities planned
- Written consent to participate in trial
Exclusion Criteria
- Overweight limiting the use of MRI
- Metal parts in body
- Claustrophobia
- Allergy to contrast agents used in trial
- Pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Aarhus University Hospital
🇩🇰Aarhus, Denmark